Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
Howard Bernstein (interim, as of 2023)
|
| gptkbp:focus |
immunotherapy
gene therapy |
| gptkbp:foundedYear |
2013
|
| gptkbp:founder |
gptkb:Armon_Sharei
|
| gptkbp:fullName |
SQZ Biotechnologies Company
|
| gptkbp:headquartersLocation |
gptkb:Watertown,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
SQZ
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Cell_Squeeze_technology
|
| gptkbp:partner |
gptkb:Pfizer
gptkb:Roche |
| gptkbp:status |
gptkb:public_company
|
| gptkbp:stockExchange |
gptkb:NYSE
|
| gptkbp:stockSymbol |
gptkb:SQZ
|
| gptkbp:website |
https://www.sqzbiotech.com/
|
| gptkbp:bfsParent |
gptkb:Serica_Energy
gptkb:SQZ_Biotech |
| gptkbp:bfsLayer |
7
|